Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Safety issue could lead to a device shortage | New ACC/AHA hypertension guidelines | Gene research links kidney health to CVD

News You Need to Know Today
Safety issue could lead to a device shortage | New ACC/AHA hypertension guidelines | Gene research links kidney health to CVD
Monday, August 18, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

FDA shares new safety concern with Medtronic catheters—warns of possible shortage in months ahead

The FDA has received multiple reports of the devices, which are designed to be malleable, failing to retain their shape. The issue has been linked to three patient injuries so far, and customers are asked to return unused devices to the manufacturer. 

READ MORE >
warning safety alert recall healthcare issue
Share on Twitter Share on Facebook Share on Linkedin

FDA shares new safety concern with Medtronic catheters—warns of possible shortage in months ahead

Share on Twitter Share on Facebook Share on Linkedin
warning safety alert recall healthcare issue
The FDA has received multiple reports of the devices, which are designed to be malleable, failing to retain their shape. The issue has been linked to three patient injuries so far, and customers are asked to return unused devices to the manufacturer. 
READ MORE >

New hypertension guidelines embrace early treatment, updated risk assessments and renal denervation

New ACC/AHA recommendations encourage clinicians to take a proactive approach when managing patients with elevated or high blood pressure. The inclusion of renal denervation in this document represents clear progress for a relatively new technology.

READ MORE >
cardiologist doctor physician patient black diverse hypertension
Share on Twitter Share on Facebook Share on Linkedin

New hypertension guidelines embrace early treatment, updated risk assessments and renal denervation

Share on Twitter Share on Facebook Share on Linkedin
cardiologist doctor physician patient black diverse hypertension
New ACC/AHA recommendations encourage clinicians to take a proactive approach when managing patients with elevated or high blood pressure. The inclusion of renal denervation in this document represents clear progress for a relatively new technology.
READ MORE >

Gene discovery highlights connection between the kidneys and cardiovascular disease

“Our findings reveal how changes in cell metabolism and increased oxidative stress can activate damaging pathways in blood vessels," explained Xiaofeng Yang, MD, a researcher at Temple University.

READ MORE >
Kidney image. About 80% of chronic kidney disease patients actually die from cardiovascular complications. Although the link between these diseases is well established, the actual biological mechanism involved has not been fully understood. But researchers at Temple University recently uncovered a key piece to this connection, where chronic kidney disease and high-fat diets combine to trigger blood vessel inflammation. Their findings are published online in Redox Biology.[1]
Share on Twitter Share on Facebook Share on Linkedin

Gene discovery highlights connection between the kidneys and cardiovascular disease

Share on Twitter Share on Facebook Share on Linkedin
Kidney image. About 80% of chronic kidney disease patients actually die from cardiovascular complications. Although the link between these diseases is well established, the actual biological mechanism involved has not been fully understood. But researchers at Temple University recently uncovered a key piece to this connection, where chronic kidney disease and high-fat diets combine to trigger blood vessel inflammation. Their findings are published online in Redox Biology.[1]
“Our findings reveal how changes in cell metabolism and increased oxidative stress can activate damaging pathways in blood vessels," explained Xiaofeng Yang, MD, a researcher at Temple University.
READ MORE >

Featured Articles

Lipoprotein(a) tests could transform patient care—is it time for universal screening?

"Lp(a) represents the most important potential potential paradigm shift in cardiovascular disease prevention that we'll experience over the next five to 10 years," Seth Baum, MD, explained in a new interview.

READ MORE >
Seth Baum, MD, FACC, FACPM, FAHA, FNLA, FASPC, Chairman of the Board for the Family Heart Foundation, past president of the American Society for Preventive Cardiology, clinical affiliate professor of biomedical science at Florida Atlantic University, and chief medical officer of Flourish Research, explains why testing for familial hypercholesterolemia (FH) and elevated Lipoprotein(a) could be critical to identify more patients with elevated risk of cardiac events, but have their LDL well controlled.
Share on Twitter Share on Facebook Share on Linkedin

Lipoprotein(a) tests could transform patient care—is it time for universal screening?

Share on Twitter Share on Facebook Share on Linkedin
Seth Baum, MD, FACC, FACPM, FAHA, FNLA, FASPC, Chairman of the Board for the Family Heart Foundation, past president of the American Society for Preventive Cardiology, clinical affiliate professor of biomedical science at Florida Atlantic University, and chief medical officer of Flourish Research, explains why testing for familial hypercholesterolemia (FH) and elevated Lipoprotein(a) could be critical to identify more patients with elevated risk of cardiac events, but have their LDL well controlled.
"Lp(a) represents the most important potential potential paradigm shift in cardiovascular disease prevention that we'll experience over the next five to 10 years," Seth Baum, MD, explained in a new interview.
READ MORE >

FDA announces Class I recalls for heart pump accessories due to safety risk

Abbott has warned healthcare providers about a new issue with the mobile power units of certain HeartMate 3 LVADs. 

READ MORE >
Recall | Product recall
Share on Twitter Share on Facebook Share on Linkedin

FDA announces Class I recalls for heart pump accessories due to safety risk

Share on Twitter Share on Facebook Share on Linkedin
Recall | Product recall
Abbott has warned healthcare providers about a new issue with the mobile power units of certain HeartMate 3 LVADs. 
READ MORE >

Advanced risk score predicts long-term survival after mitral valve surgery

The Society of Thoracic Surgeons Risk Calculator is more traditionally used to calculate short-term risks, but this single-center analysis suggests it can also anticipate issues well into the future.

READ MORE >
Tiny fragments of plastic are commonly found deep inside the human body. Heart surgery, it seems, is one of many ways these microplastics are reaching their destination.  Surgeons Operating On Patient
Share on Twitter Share on Facebook Share on Linkedin

Advanced risk score predicts long-term survival after mitral valve surgery

Share on Twitter Share on Facebook Share on Linkedin
Tiny fragments of plastic are commonly found deep inside the human body. Heart surgery, it seems, is one of many ways these microplastics are reaching their destination.  Surgeons Operating On Patient
The Society of Thoracic Surgeons Risk Calculator is more traditionally used to calculate short-term risks, but this single-center analysis suggests it can also anticipate issues well into the future.
READ MORE >

In Case You Missed It

Salary update: Cardiologist compensation stays steady—thoracic surgeon pay takes a hit

Cardiologist compensation in the United States is experiencing slow, but steady growth. How does it compare to other specialties? 

READ MORE >
Money dollar investments
Share on Twitter Share on Facebook Share on Linkedin

Salary update: Cardiologist compensation stays steady—thoracic surgeon pay takes a hit

Share on Twitter Share on Facebook Share on Linkedin
Money dollar investments
Cardiologist compensation in the United States is experiencing slow, but steady growth. How does it compare to other specialties? 
READ MORE >

Tirzepatide demonstrates cardiovascular protection in head-to-head trial with dulaglutide

Tirzepatide met the primary endpoint of non-inferiority versus dulaglutide, with an 8% lower rate of MACE events included cardiovascular death, heart attack or stroke, while delivering greater reductions in A1C and weight.

READ MORE >
Tirzepatide, a once-weekly injectable dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide receptor agonist (GLP-1), has been approved by the U.S. Food & Drug Administration (FDA) for improving glycemic control among adults with type 2 diabetes. The medication, sold by Eli Lilly and Company under the name Mounjaro, will be available in six different doses and come in an auto-injector pen.
Share on Twitter Share on Facebook Share on Linkedin

Tirzepatide demonstrates cardiovascular protection in head-to-head trial with dulaglutide

Share on Twitter Share on Facebook Share on Linkedin
Tirzepatide, a once-weekly injectable dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide receptor agonist (GLP-1), has been approved by the U.S. Food & Drug Administration (FDA) for improving glycemic control among adults with type 2 diabetes. The medication, sold by Eli Lilly and Company under the name Mounjaro, will be available in six different doses and come in an auto-injector pen.
Tirzepatide met the primary endpoint of non-inferiority versus dulaglutide, with an 8% lower rate of MACE events included cardiovascular death, heart attack or stroke, while delivering greater reductions in A1C and weight.
READ MORE >

The most anticipated trials at ESC 2025

The European Society of Cardiology 2025 congress includes 10 Hot Line sessions and 28 late-breaking science sessions to showcase the latest science.

READ MORE >
The European Society of Cardiology 2025 congress includes 10 Hot Line sessions and 28 late-breaking science sessions to showcase the latest science.ESC Congress 2022 European Society of Cardiology. #ESC #ESC2025 #ESC25
Share on Twitter Share on Facebook Share on Linkedin

The most anticipated trials at ESC 2025

Share on Twitter Share on Facebook Share on Linkedin
The European Society of Cardiology 2025 congress includes 10 Hot Line sessions and 28 late-breaking science sessions to showcase the latest science.ESC Congress 2022 European Society of Cardiology. #ESC #ESC2025 #ESC25
The European Society of Cardiology 2025 congress includes 10 Hot Line sessions and 28 late-breaking science sessions to showcase the latest science.
READ MORE >

In Other News

Healthcare AI today: AI’s odds of curing cancer, why it shouldn’t even try, agentic AI’s legal exposure, more

If not for off-limits data, AI might have a decent shot at curing cancer. 

READ MORE >
cancer chemotherapy survivor
Share on Twitter Share on Facebook Share on Linkedin

Healthcare AI today: AI’s odds of curing cancer, why it shouldn’t even try, agentic AI’s legal exposure, more

Share on Twitter Share on Facebook Share on Linkedin
cancer chemotherapy survivor
If not for off-limits data, AI might have a decent shot at curing cancer. 
READ MORE >

Nurse educator: To secure staff buy-in on AI, apply Gartner’s Hype Cycle

Nurse leaders seeking AI acceptance from those they lead would do well to apply psychological insights along with technical tips.  

READ MORE >
Nurse leader AI acceptance buy-in
Share on Twitter Share on Facebook Share on Linkedin

Nurse educator: To secure staff buy-in on AI, apply Gartner’s Hype Cycle

Share on Twitter Share on Facebook Share on Linkedin
Nurse leader AI acceptance buy-in
Nurse leaders seeking AI acceptance from those they lead would do well to apply psychological insights along with technical tips.  
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Weekend Edition | April 7, 2018
Female physicians earned $105K less than men in 2017; cardiologists No. 6 in pay

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …346
    • Page 347
    • Page 348
    • Page 349
    • Page 350
    • Page 351
    • Page 352
    • Page 353
    • Current page 354
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup